Not available
Quote | Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH)
Last: | $44.25 |
---|---|
Change Percent: | 1.68% |
Open: | $43.76 |
Close: | $43.52 |
High: | $44.83 |
Low: | $43.76 |
Volume: | 126,847 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH)
2024-03-20 15:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-08 10:21:57 ET More on Teva Pharmaceutical Teva And Alvotech: Simlandi Approval Opens New Generic Market Opportunities Teva Pharmaceutical: I Need To See Top-Line Growth Return Before Starting A Position A Review Of Teva's Prospects UroGen falls as Te...
Message Board Posts | Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH)
Subject | By | Source | When |
---|---|---|---|
AMPHASTAR: NEW FDA APPROVAL OPENS A FLOODGATE OF OPPORTUNITIES$AMPHExcited to share an article about | | mwn | 03/12/2023 9:32:53 PM |
I've bought some $AMPH at $31. Great products | Gentlemen Prefer Bonds | investorshub | 06/29/2022 5:36:36 PM |
$AMPH buy 42.3299 | stocktrademan | investorshub | 04/17/2022 8:52:53 AM |
$AMPH 50/200sma crossed here...Nice bullish sign. | Golden Cross | investorshub | 06/24/2020 10:05:50 PM |
fda approval | atarabih | investorshub | 06/09/2020 10:22:00 AM |
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
2024-03-20 15:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
RANCHO CUCAMONGA, CA / ACCESSWIRE / March 6, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, will be presenting at the Barclays 26 th Annual Global Healthcare Conference on Wednesday, M...
2024-02-28 23:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...